Deep Learning-based Classification and Prediction of Radiation Dermatitis in Head and Neck Patients
NCT05607225 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2022-11-07
Summary
to develop a deep learning-based model to grade the severity of radiation dermatitis (RD) and predict the severity of radiation dermatitis in patients with head and neck cancer undergoing radiotherapy, so as to provide support for doctors' diagnosis and prediction.
Conditions
- Radiation Dermatitis
- Head and Neck Cancer
Sponsors & Collaborators
-
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
lead OTHER
Principal Investigators
-
Ye Zhang, MD · Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
-
Li Ma, MD · Shenzhen Cancer Hospital, Chinese Academy of Medical Sciences
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-01
- Primary Completion
- 2025-06-30
- Completion
- 2025-06-30
Countries
- China
Study Locations
More Related Trials
-
Individualized Elective Neck Irradiation in NPC Patients
NCT06241612 ·Status: RECRUITING ·Phase: PHASE3
-
Hypofractionated Radiotherapy for HNSCC in Elderly Patients
NCT06768125 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Optimising Radiation Therapy in Head and Neck Cancers Using Functional Image-Guided Radiotherapy and Novel Biomarkers
NCT04242459 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Laser Therapy for the Prevention of Radiodermatitis in Head and Neck Patients
NCT02738268 ·Status: COMPLETED ·Phase: NA
-
Predicting Radiological Extranodal Extension in Oropharyngeal Carcinoma Patients Using AI
NCT05565313 ·Status: ACTIVE_NOT_RECRUITING
-
Retrospective Study on the Prediction of Radiation-induced Brain Injury in Patients With Nasopharyngeal Carcinoma
NCT06244394 ·Status: COMPLETED
-
Delineation of Target Volume of Stereotactic Radiotherapy for Spinal Tumors
NCT06587022 ·Status: RECRUITING
-
Systemic Anti-tumor Activity and Safety of the Combination of SBRT and Concurrent PD-1 Blockade in Metastatic RCC.
NCT06327178 ·Status: RECRUITING
-
Prediction Model for Lateral Lymph Node Metastasis
NCT04635488 ·Status: UNKNOWN
-
Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC
NCT02688036 ·Status: UNKNOWN ·Phase: PHASE3
-
Dose Constraints for the Temporal Lobes of Intensity-modulated Radiotherapy Treatment Plans for Nasopharyngeal Carcinoma
NCT03539250 ·Status: UNKNOWN ·Phase: NA
-
Spinal met_radiosurgery/SBRT Study
NCT01231061 ·Status: COMPLETED ·Phase: PHASE2
-
Tumor Response in Hypofractionated Radiotherapy
NCT02854449 ·Status: UNKNOWN
-
Photon/Proton Radiation Therapy for Carcinoma of the Skin of the Head and Neck
NCT00797043 ·Status: TERMINATED
-
Target Volume Delineation After NACT in LA-NPCarcinoma Patients Treated With NACT+ CCRT
NCT03283293 ·Status: COMPLETED ·Phase: PHASE2
-
Margin-Based Vs. Robust Photon Radiotherapy Planning in IMRT of HN-SQCC
NCT03552965 ·Status: COMPLETED ·Phase: NA
-
Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy
NCT04892849 ·Status: RECRUITING
-
Whole Versus Partial Vertebral Body IMRT for Spinal Metastases
NCT02972229 ·Status: UNKNOWN ·Phase: NA
-
Functional Imaging in HNC Undergoing Chemoradiation
NCT00837980 ·Status: UNKNOWN
-
Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer
NCT02379039 ·Status: COMPLETED
-
Effectiveness of Stereotactic RadioTherapy in Solid Primary Inoperable and Oligometastatic Cancer
NCT03461822 ·Status: UNKNOWN
-
Do Markers of Systemic Inflammatory Response and Tumor Metabolism Indicate Radioresistance in Head and Neck Cancer?
NCT05217212 ·Status: RECRUITING
-
Stereotactic Radiosurgery in Patients With Head and Neck Region Tumours
NCT06472570 ·Status: RECRUITING ·Phase: NA
-
Studying Mechanisms of Radiation Therapy Resistance in Samples From Younger Patients With Rhabdomyosarcoma
NCT01626170 ·Status: COMPLETED
-
HN-BIO 02: A Phase II Randomized Study of the Effects of Delayed Elective Radiotherapy on Head and Neck MRI and Immune Response Biomarkers
NCT06487403 ·Status: RECRUITING ·Phase: NA